|
Product Details:
Payment & Shipping Terms:
|
| Cas No.: | 167933-07-5 | Product Name: | Flibanserin |
|---|---|---|---|
| Usage: | Pharmaceutical Raw Material | Appearance: | White Powder |
| Assay: | 99% | Grade: | Pharmaceutical Grade |
| Storage: | Cool Dried Storage | Application: | Pharmaceutical Raw Intermediates |
| High Light: | pharm raw material,raw steroid powders |
||
Detail:
Name: Flibanserin
Chemical formula: C20H21F3N4O
Molecular Weight: 390.4
Assay: 99%
CAS: 167933-07-5
CBNumber: CB91178756
Apperance: white powder
Usage: kind of sex enhancer medicion.
Description:
Flibanserin (INN, USAN), sold under the trade name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD).The medication increases the number of satisfying sexual events per month by about one half to one over placebo from a starting point of about two to three.
HSDD was recognized as a distinct sexual function disorder for more than 30 years, but was removed from the Diagnostic and Statistical Manual of Mental Disorders in 2013, and replaced with a new diagnosis called female sexual interest/arousal disorder (FSIAD).
COA
| Items | Specification |
| Appearance | white crystals or crystalline powder, has a faint, characteristic odor and bitter taste |
| Solubility | freely soluble in water and 95%ethanol, sparingly soluble in acetic anhydride and practically insoluble in diethyl ether |
| pH | 3.5-4.5 |
| Identification | 1, red to dark purple color appears with(III)iron chloride |
| 2, light red precipitate formed with reinecke salt TS | |
| 3, UV spectrum meet the reference | |
| 4, solution (1%) responds to the qualitative test for chloride | |
| Melting point | 139-143 celcius degree |
| Clarity and color of solution | clear and colorless |
| Sulfate | 0.048%max |
| Heavy metals | 10ppm max |
| As | 2ppm max |
| Organic acid(0.1M NaOH) | 0.54ml max |
| Loss on drying | 0.5% max |
| Residue on ignition | 0.1%max |
| Residual organic Solvents (GC) | Xylol 0.217%max |
| Isopropanol 0.5%max | |
| Related substances(HPLC) | Total impurity 1.5%max |
| Single impurity0.5%max | |
| Free P-chloro phenoxy acetic 0.5%max | |
| Count of bacteria | bacillus 1000/1g max |
| Mildew 100/1g max | |
| Microzyme 100/1g max | |
| Assay(C12H16CINO3.HCl,on dry basis) | 98%min |
Function:
(1) dizziness
(2) nausea
(3) Tiredness
(4) difficulty falling asleep or staying asleep
(5) dry mouth
Application:
A new drug designed to boost sexual desire in women is controversial for some and eagerly awaited by others, but it's hit a potentially serious snag. The drug didn't boost women's desire any more than a placebo in two clinical trials. The Food and Drug Administration posted the clinical trial results on its website today in advance of a committee meeting on Friday, when a panel of experts will vote whether or not to recommend approval of the drug called flibanserin. (The FDA usually follows the recommendations of its expert panels. ) Although there was a slight increase in the number of sexually satisfying events flibanserin users had each month, the FDA staff who reviewed the results said the so-called response rate isn't "particularly compelling. "
Packing:
Sex Product Flibanserin CAS 167933-07-5 for Female Sexual Enhancer
Contact Person: bruce
Tel: +8618874586545
